Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents
AP Banning, S Westaby, MC Morice… - Journal of the American …, 2010 - jacc.org
Objectives: This study was designed to compare contemporary surgical revascularization
(coronary artery bypass graft surgery [CABG]) versus TAXUS Express (Boston Scientific …
(coronary artery bypass graft surgery [CABG]) versus TAXUS Express (Boston Scientific …
Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention …
AP Kappetein, SJ Head, MC Morice… - European Journal of …, 2013 - academic.oup.com
OBJECTIVES This prespecified subgroup analysis examined the effect of diabetes on left
main coronary disease (LM) and/or three-vessel disease (3VD) in patients treated with …
main coronary disease (LM) and/or three-vessel disease (3VD) in patients treated with …
Bypass surgery or stenting for left main coronary artery disease in patients with diabetes
M Milojevic, PW Serruys, JF Sabik, DE Kandzari… - Journal of the American …, 2019 - jacc.org
Abstract Background: The randomized EXCEL (Evaluation of XIENCE versus Coronary
Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial reported a …
Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial reported a …
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease …
Background—The Synergy Between Percutaneous Coronary Intervention With TAXUS and
Cardiac Surgery (SYNTAX) trial demonstrated that in patients with 3-vessel or left main …
Cardiac Surgery (SYNTAX) trial demonstrated that in patients with 3-vessel or left main …
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the …
DJFM Thuijs, AP Kappetein, PW Serruys, FW Mohr… - The Lancet, 2019 - thelancet.com
Summary Background The Synergy between PCI with Taxus and Cardiac Surgery
(SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention …
(SYNTAX) trial was a non-inferiority trial that compared percutaneous coronary intervention …
Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease
A Javaid, DH Steinberg, AN Buch, PJ Corso… - Circulation, 2007 - Am Heart Assoc
Background—Advances in coronary artery bypass grafting (CABG) surgery and
percutaneous coronary intervention (PCI) with drug-eluting stents have dramatically …
percutaneous coronary intervention (PCI) with drug-eluting stents have dramatically …
Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass …
MC Morice, PW Serruys, AP Kappetein, TE Feldman… - Circulation, 2010 - Am Heart Assoc
Background—The prospective, multinational, randomized Synergy Between Percutaneous
Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial was designed to …
Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial was designed to …
Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the …
AP Kappetein, KD Dawkins, FW Mohr… - European journal of …, 2006 - academic.oup.com
Objective: Percutaneous coronary intervention with drug-eluting stents is challenging
coronary artery bypass grafting (CABG) as the gold standard for treatment of three-vessel …
coronary artery bypass grafting (CABG) as the gold standard for treatment of three-vessel …
Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome
MJ Mack, AP Banning, PW Serruys, MC Morice… - The Annals of thoracic …, 2011 - Elsevier
BACKGROUND: Diabetes mellitus increases adverse outcomes after coronary
revascularization; however, the impact of metabolic syndrome is unclear. We examined the …
revascularization; however, the impact of metabolic syndrome is unclear. We examined the …
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial
AP Kappetein, TE Feldman, MJ Mack… - European heart …, 2011 - academic.oup.com
Aims Long-term randomized comparisons of percutaneous coronary intervention (PCI) to
coronary artery bypass grafting (CABG) in left main coronary (LM) disease and/or three …
coronary artery bypass grafting (CABG) in left main coronary (LM) disease and/or three …